Abstract
This article contains first person accounts in narrative and visual form created by clients and family members who have participated in the Early Detection and Intervention for the Prevention of Psychosis Program (EDIPPP). By the time most individuals join EDIPPP they have been experiencing a confusing constellation of thought and behavior changes. For most, EDIPPP signifies the next step in a journey of trying to reclaim a sense of agency in their lives and promise for the future. Understanding the process youth and families go through to make meaning of a “high risk” indication is critical for the clinicians who work with these families. By highlighting these first person accounts and the story they tell, we strive to contribute to this understanding and thereby enrich our discussion of the early detection and intervention for psychosis with the perspectives of individuals participating in our study. These narratives point to the potential value of further research focused specifically on how youth and families come to understand being at risk for psychosis.
Keywords: Adolescents, first person accounts, psychosis, schizophrenia, prodromal psychosis, high risk, recovery
Adolescent Psychiatry
Title:In the First Person: A Window into the Experience of Early Psychosis and Recovery
Volume: 2 Issue: 2
Author(s): Margaret Migliorati, Melina Salvador, Elizabeth Spring-Nichols, Sarah Lynch Tamara Sale and Steven Adelsheim
Affiliation:
Keywords: Adolescents, first person accounts, psychosis, schizophrenia, prodromal psychosis, high risk, recovery
Abstract: This article contains first person accounts in narrative and visual form created by clients and family members who have participated in the Early Detection and Intervention for the Prevention of Psychosis Program (EDIPPP). By the time most individuals join EDIPPP they have been experiencing a confusing constellation of thought and behavior changes. For most, EDIPPP signifies the next step in a journey of trying to reclaim a sense of agency in their lives and promise for the future. Understanding the process youth and families go through to make meaning of a “high risk” indication is critical for the clinicians who work with these families. By highlighting these first person accounts and the story they tell, we strive to contribute to this understanding and thereby enrich our discussion of the early detection and intervention for psychosis with the perspectives of individuals participating in our study. These narratives point to the potential value of further research focused specifically on how youth and families come to understand being at risk for psychosis.
Export Options
About this article
Cite this article as:
Migliorati Margaret, Salvador Melina, Spring-Nichols Elizabeth, Tamara Sale Sarah Lynch and Adelsheim Steven, In the First Person: A Window into the Experience of Early Psychosis and Recovery , Adolescent Psychiatry 2012; 2 (2) . https://dx.doi.org/10.2174/2210676611202020146
DOI https://dx.doi.org/10.2174/2210676611202020146 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Glycine Site Modulators and Glycine Transporter-1 Inhibitors as Novel Therapeutic Targets for the Treatment of Schizophrenia
Current Neuropharmacology Editorial: Financial Crisis, Drug Compliance and Cardiovascular Health-the GREECS Case?
Current Vascular Pharmacology Survivin Modulators: An Updated Patent Review (2011 - 2015)
Recent Patents on Anti-Cancer Drug Discovery Stem Cell Niche in Tissue Homeostasis, Aging and Cancer
Current Medicinal Chemistry Trends and Applications of Brain Computer Interfaces
Current Signal Transduction Therapy Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia
Current Drug Therapy Assessing the Relationship between Health Utilities, Quality of Life, and Health Care Costs in Alzheimers Disease: The CATIE-AD Study
Current Alzheimer Research Role of β 2-Adrenoceptor Activation in Sepsis-Induced Renal Inflammation
Current Immunology Reviews (Discontinued) Enzyme Inhibitors as the Attractive Targets for the Treatment of Various Diseases
Current Medicinal Chemistry Why Some Messages Speak Better: Child Immunization in the News and on the Internet
Current Drug Safety Lipid Based Nanocarriers for Delivery of Anti-HIV Drugs: A Mini Review
Nanoscience & Nanotechnology-Asia A Pilot Study of Hippocampal Activity During a Verbal Memory Task in Depressed Young Adults
Adolescent Psychiatry Analgesic Considerations for Liver Transplantation Patients
Current Clinical Pharmacology Gene Expression Profiling and its Practice in Drug Development
Current Genomics Molecular Iodine in the Synthesis of Chromone-type Compounds
Current Organic Synthesis Computational Study on the Role of γ-Synuclein in Inhibiting the α-Synuclein Aggregation
Central Nervous System Agents in Medicinal Chemistry The Chemokine CXCL10 as a Therapeutic Target in Animal Models of Neuroinflammatory Disease
Letters in Drug Design & Discovery Ligand based Drug Design of New Heterocyclic Imines of GABA Analogues: A Molecular Docking Approach for the Discovery of New GABA-AT Inhibitors
Central Nervous System Agents in Medicinal Chemistry Molecular and Pharmaceutical Aspects of Novel Methods and Materials for the Prevention of Tooth Structure Loss
Current Pharmaceutical Biotechnology Potential Therapeutic Targets in Energy Metabolism Pathways of Breast Cancer
Current Cancer Drug Targets